520. Arming a Tumor Targeted Oncolytic HSV Vector With MMP9 for Enhanced Distribution and Killing Activity
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33329-9
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV